NPPA extends timeline for trade margin cap imposed on medical devices like pulse oximeter, nebulizer, glucometer etc. till 30th June, 2023

The National Pharmaceutical Pricing Authority has capped the trade margin of five medical devices (i) Pulse Oximeter, (ii) Blood Pressure Monitoring Machine, (iii) Nebulizer, (iv) Digital Thermometer, (v) Glucometer at first point of sale of the product (price to distributor) for fixation of Maximum Retail Price.

During the pandemic, the Government through Order dated 14-07-2021 had placed a cap on the trade margin of the above-mentioned.

The revised price was first effective till 31st January, 2022, which was extended to 31st July, 2022 then 31st December 2022 then to 31st March, 2023 and has now been further extended till 30th June 2023.

Please refer to the attached document for further details on the process of calculation of Maximum Retail Price and Price to Distributor.

Source: National Pharmaceutical Pricing Authority